Top Markets
Coin of the day
CVS Health Corporation CVS Health Corporation

CVS Health Corporation

CVS
Rank in Stocks #229
CVS Health Corporation provides health services in the United States. The... CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Share Price
$71.29
Market Cap
$90.70B
Change (1 day)
-0.27%
Change (1 year)
5.51%
Country
US
Trade CVS Health Corporation (CVS)

Category

P/E ratio for CVS Health Corporation (CVS)
P/E ratio as of March 2026 TTM: 54.69
According to CVS Health Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 54.69. At the end of 2024 the company had a P/E ratio of 12.25.
P/E ratio history for CVS Health Corporation from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 54.69 -3.84%
2025 56.87 364.30%
2024 12.25 0.73%
2023 12.16 -57.12%
2022 28.36 66.77%
2021 17.01 36.56%
2020 12.45 -14.52%
2019 14.57 -112.65%
2018 -115.16 -1,131.19%
2017 11.17 -29.87%
2016 15.92 -23.70%
2015 20.87 -13.31%
2014 24.08 26.94%
2013 18.97 19.27%
2012 15.90 0.91%
2011 15.76 13.64%
2010 13.87 10.98%
2009 12.50 -2.60%
2008 12.83 -36.31%
2007 20.15 8.73%
2006 18.53 5.86%
2005 17.50 5.53%
2004 16.59 26.24%
2002 13.14 -53.68%
2001 28.37 -9.74%
2000 31.43 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
21.29 -61.06%
US
11.93 -78.19%
US
11.42 -79.11%
US
16.76 -69.36%
US
16.06 -70.64%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.